Diferencia entre revisiones de «Template:Brain abscess antibiotics»
Sin resumen de edición |
(Marked this version for translation) |
||
| Línea 2: | Línea 2: | ||
<translate> | <translate> | ||
====Otogenic source==== | ====Otogenic source==== <!--T:1--> | ||
<!--T:2--> | |||
*[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | *[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | ||
====Sinogenic or odontogenic source==== | ====Sinogenic or odontogenic source==== <!--T:3--> | ||
<!--T:4--> | |||
*[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | *[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | ||
====Penetrating trauma or neurosurgical procedures==== | ====Penetrating trauma or neurosurgical procedures==== <!--T:5--> | ||
<!--T:6--> | |||
*[[Special:MyLanguage/Vancomycin|Vancomycin]] 15mg/kg IV q12hr + [[Special:MyLanguage/ceftazidime|ceftazidime]] 2gm IV q8hr | *[[Special:MyLanguage/Vancomycin|Vancomycin]] 15mg/kg IV q12hr + [[Special:MyLanguage/ceftazidime|ceftazidime]] 2gm IV q8hr | ||
====Hematogenous source==== | ====Hematogenous source==== <!--T:7--> | ||
<!--T:8--> | |||
*[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | *[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | ||
====No obvious source==== | ====No obvious source==== <!--T:9--> | ||
<!--T:10--> | |||
*[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | *[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 2gm IV q6hr + [[Special:MyLanguage/metronidazole|metronidazole]] 500mg IV q6hr | ||
</translate> | </translate> | ||
Revisión del 04:34 26 ene 2026
Otogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
Sinogenic or odontogenic source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
Penetrating trauma or neurosurgical procedures
- Vancomycin 15mg/kg IV q12hr + ceftazidime 2gm IV q8hr
Hematogenous source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
No obvious source
- Cefotaxime 2gm IV q6hr + metronidazole 500mg IV q6hr
